Welcome : Guest

BIOCHIPS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others. The report further analyzes the market by the following Applications: Research, Diagnostics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 79 companies including many key and niche players such as -

Affymetrix, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Cepheid Inc.
Fluidigm Corporation

Click here to request a full list of companies covered in the report...

Code: MCP-1026
Price: $4950
Companies: 79
Pages: 292
Date: February 2016
Market Data Tables: 91
  Status: * New Report



TABLE OF CONTENTS


  BIOCHIPS (Complete Report) Pages : 292   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Biochips - A Primer.....II-1
Expanding Application Areas.....II-1
1$100
   Current & Future Analysis.....II-21$100
   DNA Biochips Lead the Application Front.....II-3
Protein Biochips – Set for Robust Expansion.....II-3
1$100
   Lab-on-a-Chip: Fusion of Nanotechnology & Genetic Engineering.....II-4
Key Applications of Lab-on-a-Chip Technology.....II-4
Molecular Biology and Lab-On-A-Chip.....II-4
1$100
   Proteomics and Lab-On-A-Chip.....II-5
Cell Biology and Lab-On-A-Chip.....II-5
Chemistry and Lab-On-A-Chip.....II-5
Growth Drivers/Market Trends.....II-5
1$100
   Proteomics and Genomics Drive Demand for Biochips.....II-6
Growing Preference for DNA/Protein Biochips in Personalized Medicine.....II-6
1$100
   Application of Biochips in Drug Discovery – A Strong Growth Driver.....II-7
Cancer: An Important Driver for the Biochips Market.....II-7
1$100
   Table 1: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart).....II-81$350
   Table 2: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal, and Liver Cancers (includes corresponding Graph/Chart).....II-9

Table 3: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus, and Liver Cancers (includes corresponding Graph/Chart).....II-9
1$350
   Increasing Prevalence of Lifestyle Diseases Boost Diagnostic Microarray
  Market.....II-10
Table 4: Global Diabetes Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart).....II-10
1$350
   Table 5: Percentage Increase in DM Incidence among Ages 20-79 Worldwide by Geographic Region: 2013-2035 (includes corresponding Graph/Chart).....II-11
Government Efforts to Promote Biochip Technology.....II-11
1$350
   Integrating Tools with Diagnostic Capabilities with Smartphones – A Futuristic
  Trend.....II-12
1$100
   Microfluidic and Lab-on-a-chip Devices for Pharmacogenomics.....II-13
Lab-on-a-Chip System for Better Pulmonary Disease Outcome.....II-13
1$100
   Industry Challenges.....II-14
Standardization: A Key Challenge.....II-14
1$100
   High Costs Restrain Growth.....II-15
Precise Protein Detection: A Challenge.....II-15
1$100
   Innovations in the Biochips Industry.....II-162$200
   Biochip Innovations in Drug Discovery Applications.....II-18
HuRELflow.....II-18
MetaChip and Subsequent Versions.....II-18
1$100
   Lab-on-a-Chip Devices in Smart Delivery of Drugs.....II-19
Biochips from AYOXXA: A Giant Leap in Protein Multiplexing.....II-19
1$100
   Key Developments in the Past.....II-202$200
   Industry Structure.....II-22
Major Participants.....II-22
Affymetrix: A Pioneer Player.....II-22
Growing Partnerships between Pharma and Biotech Companies.....II-22
1$100
   Outsourcing: A Positive Trend.....II-231$100
   Biochips – Complex Blend of Biochemistry and Electronics.....II-24
Historical Perspective.....II-24
1$100
   Promising Biochips Promote Biological Research.....II-251$100
   Lab-on-a-chip: An Enabled Technology.....II-26
Utility.....II-26
1$100
   Evolution and Segmentation.....II-27
Differing Perspectives.....II-27
Classification of Biochips.....II-27
1$100
   Need for Biochips.....II-281$100
   Manufacturing Systems Used in Biochip Manufacture.....II-29
Working of a Biochip.....II-29
DNA Transcription & Translation through A Biochip.....II-29
1$100
   A Functional Model.....II-30
Cocktail of Disparate Technically Specialized Applications.....II-30
Biochips: By-product of Multi-disciplinary Sciences.....II-30
Nanotechnology.....II-30
BioMEMS.....II-30
1$100
   Microfluidics.....II-311$100
   Micro Total Analysis System.....II-321$100
   Chip Architecture.....II-33
Essence of a Biochip.....II-33
Concept of a Microarray.....II-33
Microarray Modules.....II-33
1$100
   High Degree of Automation Spurs Biochips Use.....II-34
Microfabrication Technology in Biochips made from Polymer and Plastics.....II-34
Micro-optics in Biochips.....II-34
1$100
   Liquid Handling Through Micro-Dispensers.....II-35
Capillary Electrophoresis and Electrochemical Detectors.....II-35
Other Technologies.....II-35
Management of Bio-information.....II-35
1$100
   Scanning.....II-36
Microarray Database Management.....II-36
Classification of DNA Chips.....II-36
General Description of Spotted cDNA Microarrays.....II-36
Spotted DNA Arrays.....II-36
1$100
   Spotted cDNA Versus Spotted Oligonucleotide Arrays.....II-37
Limitations of Conventional cDNA Microarrays.....II-37
Protein Biochips.....II-37
1$100
   General Applications of Protein Biochips:.....II-38
Challenges in the Design of a Protein Biochip.....II-38
1$100
   Limitations of Protein Chip Technology.....II-391$100
   Concluding Remarks for Protein Biochips.....II-401$100
   Biochip Uses.....II-411$100
   Pharmaceutical Investigation.....II-42
Medical Diagnostics.....II-42
1$100
   Advantages of Biosensor Chip Technology.....II-43
Forensics.....II-43
Transplantation Screening.....II-43
Identity Testing.....II-43
Water and Environmental Testing.....II-43
Food Industry.....II-43
1$100
   Veredus Laboratories and AVA Launch VereVet™ Lab-on-Chip Application.....II-44
Eurofins Scientific Launches Analytical DNA Chip Technology.....II-44
Agilent Technologies Introduces Updated SurePrint Microarrays.....II-44
Agilent Technologies Launches GenetiSure Pre-Screen Microarray.....II-44
Agilent Technologies Launches Updates to SurePrint miRNA Microarrays.....II-44
Clontech Laboratories Launches DNA SMART ChIP-Seq Kit.....II-44
1$100
   PerkinElmer Launches LabChip® GX Touch Automated Electrophoresis Systems.....II-45
Cancer Genetics Launches Urogenital Cancer Array UroGenRA.....II-45
A STAR and Veredus Launch VereTrop™ Biochip.....II-45
1$100
   Sengenics Acquires Oxford Gene Technology’s Protein Array Technology.....II-46
Immucor Acquires Sentilus.....II-46
SQI Diagnostics Expands Collaboration with Global Pharmaceutical Company.....II-46
Agenix Enters into Cross-Licensing Agreement with Arrayjet Limited.....II-46
CombiMatrix and Manhattan Labs Enter into Distribution Partnership.....II-46
Sequenom and CombiMatrix Enter Into Collaboration Agreement.....II-46
1$100
   Affymetrix, Inc. (US).....II-47
Agilent Technologies, Inc. (US).....II-47
1$100
   Bio-Rad Laboratories, Inc. (US).....II-481$100
   Cepheid Inc. (US).....II-49
Fluidigm Corporation (US).....II-49
1$100
   GE Healthcare Ltd. (UK).....II-50
Hoffman-La-Roche Ltd. (Switzerland).....II-50
1$100
   Illumina, Inc. (US).....II-51
Ocimum Biosolutions Ltd. (India).....II-51
1$100
   PerkinElmer, Inc. (US).....II-52
Takara Bio, Inc. (Japan).....II-52
1$100
   Clontech Laboratories, Inc. (US).....II-53
Thermo Fisher Scientific Inc. (US).....II-53
2$200
   Table 6: World Recent Past, Current & Future Analysis for Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-551$350
   Table 7: World Historic Review for Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-561$350
   Table 8: World 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-571$350
   Table 9: World Recent Past, Current & Future Analysis for DNA Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-581$350
   Table 10: World Historic Review for DNA Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-591$350
   Table 11: World 14-Year Perspective for DNA Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-601$350
   Table 12: World Recent Past, Current & Future Analysis for Protein Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-611$350
   Table 13: World Historic Review for Protein Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-621$350
   Table 14: World 14-Year Perspective for Protein Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-631$350
   Table 15: World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-641$350
   Table 16: World Historic Review for Lab-on-a-Chip by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-651$350
   Table 17: World 14-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-661$350
   Table 18: World Recent Past, Current & Future Analysis for Other Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-671$350
   Table 19: World Historic Review for Other Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-681$350
   Table 20: World 14-Year Perspective for Other Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-691$350
   Table 21: World Recent Past, Current & Future Analysis for Biochips by Application - Research, Diagnostics, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-701$350
   Table 22: World Historic Review for Biochips by Application - Research, Diagnostics, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-711$350
   Table 23: World 14-Year Perspective for Biochips by Application - Percentage Breakdown of Dollar Sales for Research, Diagnostics, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-721$350
   A. Market Analysis.....III-1
United States: The Global Leader for Biochips.....III-1
Rising Demand in Biotechnology and Life Science Research Applications.....III-1
1$75
   Lab-on-a-Chip: The Leading Segment.....III-2
Rapid Growth for Protein Biochips.....III-2
1$75
   DNA Biochip Market.....III-3
Growth Drivers.....III-3
Demand for Personalized Medicine Drives Market for Biochips.....III-3
Aging Population: A Strong Demographic Driver.....III-3
1$75
   Table 24: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart).....III-4

Table 25: The US Population Breakdown by Age Group (2014) (includes corresponding Graph/Chart).....III-4
1$200
   Growing Incidence of Cancer & Lifestyle Disorders.....III-5
Opportunity Indicators: Statistics Depicting Increasing Incidence of Cancer and
  Lifestyle Disorders.....III-5
Table 26: The US Cancer Incidence by Gender (2014): No. of Reported New Cases for Men and Women (includes corresponding Graph/Chart).....III-5
1$200
   Table 27: The US Cancer Incidence by Affected Site (2014): Number of New Cancer Cases (includes corresponding Graph/Chart).....III-61$200
   Table 28: Prevalence of Diabetes Mellitus in the US (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group for the US (includes corresponding Graph/Chart).....III-7
Competition.....III-7
Product Introductions.....III-7
1$200
   Strategic Corporate developments.....III-81$75
   Select Key Players.....III-96$450
   B. Market Analytics.....III-15
Table 29: The US Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-15
1$200
   Table 30: The US Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-161$200
   Table 31: The US 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-171$200
   A. Market Analysis.....III-18
Current & Future Analysis.....III-18
Rising Incidence of Chronic Diseases Spurs Biochips Demand.....III-18
1$75
   Opportunity Indicators for Biochips Market:.....III-19
Table 32: New Cancer Cases in Canada by Gender and Affected Site (2012) (includes corresponding Graph/Chart).....III-19
1$200
   Table 33: New Cancer Cases in Canada by Province (2012) (includes corresponding Graph/Chart).....III-201$200
   Table 34: Prevalence of Diabetes Mellitus in Canada (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group (includes corresponding Graph/Chart).....III-21
Strategic Corporate Development.....III-21
1$200
   B. Market Analytics.....III-22
Table 35: Canadian Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-22
1$200
   Table 36: Canadian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-231$200
   Table 37: Canadian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-241$200
   A. Market Analysis.....III-25
Elderly Population Boosts the Biochip Market.....III-25
Table 38: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart).....III-25
1$200
   B. Market Analytics.....III-26
Table 39: Japanese Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-26
1$200
   Table 40: Japanese Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-271$200
   Table 41: Japanese 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-281$200
   A. Market Analysis.....III-29
Current & Future Analysis.....III-29
Leader in the DNA Biochip Segment.....III-29
Lab-on-chip Market in Europe.....III-29
1$75
   European Advancements Shape Diagnostic Procedures.....III-30
Ageing Population Boosts Demand.....III-30
1$75
   Table 42: European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart).....III-311$200
   Opportunity Indicator for the Biochips Market: European Personalized Medicine Market
  Exhibits Robust Growth.....III-32
Increasing Incidence of Cancer Drives Biochips Demand.....III-32
1$75
   Table 43: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart).....III-331$200
   B. Market Analytics.....III-34
Table 44: European Recent Past, Current & Future Analysis for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-34
1$200
   Table 45: European Historic Review for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-351$200
   Table 46: European 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-361$200
   Table 47: European Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-371$200
   Table 48: European Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-381$200
   Table 49: European 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-391$200
   A. Market Analysis.....III-40
Current & Future Analysis.....III-40
Product Introduction.....III-40
1$75
   B. Market Analytics.....III-41
Table 50: French Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-41
1$200
   Table 51: French Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-421$200
   Table 52: French 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-431$200
   A. Market Analysis.....III-44
Current & Future Analysis.....III-44
Berlin, Brandenburg and Biochips.....III-44
1$75
   B. Market Analytics.....III-45
Table 53: German Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-45
1$200
   Table 54: German Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-461$200
   Table 55: German 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-471$200
   A. Market Analysis.....III-48
Current & Future Analysis.....III-48
B. Market Analytics.....III-48
Table 56: Italian Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-48
1$200
   Table 57: Italian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-491$200
   Table 58: Italian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-501$200
   A. Market Analysis.....III-51
Current & Future Analysis.....III-51
Strategic Corporate development.....III-51
GE Healthcare Ltd. – A Key Player.....III-51
1$75
   B. Market Analytics.....III-52
Table 59: UK Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-52
1$200
   Table 60: UK Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-531$200
   Table 61: UK 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-541$200
   Market Analysis.....III-55
Table 62: Spanish Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-55
1$200
   Table 63: Spanish Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-561$200
   Table 64: Spanish 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-571$200
   Market Analysis.....III-58
Table 65: Russian Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-58
1$200
   Table 66: Russian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-591$200
   Table 67: Russian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-601$200
   Market Analysis.....III-61
Table 68: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-61
1$200
   Table 69: Rest of Europe Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-621$200
   Table 70: Rest of Europe 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-631$200
   A. Market Analysis.....III-64
Increased Healthcare Spending Boosts the Biochips Market.....III-64
India & China Offer Significant Growth Opportunities.....III-64
1$75
   Table 71: China and India Lead Global Population (July 2013): Table Depicting China and India’s Huge Population Vis-a-vis Other Countries’ Population (in Million) by Age Group (includes corresponding Graph/Chart).....III-65
Rising Diabetes Incidence in Asia-Pacific Offers Significant Growth
  Opportunities.....III-65
1$200
   Table 72: Prevalence of Diabetes Mellitus in South East Asia (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka.....III-661$200
   Table 73: Prevalence of Diabetes Mellitus in Western Asia-Pacific Regions (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region.....III-671$200
   B. Market Analytics.....III-68
Table 74: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-68
1$200
   Table 75: Asia-Pacific Historic Review for Biochips by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-691$200
   Table 76: Asia-Pacific 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for China, and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-701$200
   Table 77: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-711$200
   Table 78: Asia-Pacific Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-721$200
   Table 79: Asia-Pacific 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-731$200
   A. Market Analysis.....III-74
Basic Environment and Commercial Development.....III-74
1$75
   Biochip Research Institutes.....III-75
Favorable Personalized Medicine Market Boosts Demand for Biochips.....III-75
1$75
   B. Market Analytics.....III-76
Table 80: Chinese Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-76
1$200
   Table 81: Chinese Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-771$200
   Table 82: Chinese 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-781$200
   A. Market Analysis.....III-79
India: Growing Investments in Pharmacogenomics Research Drives Biochips
  Market.....III-79
Product Introductions.....III-79
1$75
   Strategic Corporate Development.....III-80
Ocimum Biosolutions Ltd. – A Key India-based Player.....III-80
1$75
   B. Market Analytics.....III-81
Table 83: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-81
1$200
   Table 84: Rest of Asia-Pacific Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-821$200
   Table 85: Rest of Asia-Pacific 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-831$200
   Market Analysis.....III-84
Table 86: Latin American Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-84
1$200
   Table 87: Latin American Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-851$200
   Table 88: Latin American 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-861$200
   Market Analysis.....III-87
Table 89: Rest of World Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-87
1$200
   Table 90: Rest of World Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-881$200
   Table 91: Rest of World 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-891$200
  
Total Companies Profiled: 79 (including Divisions/Subsidiaries - 86)

Region/Country Players

The United States 45 Canada 2 Japan 6 Europe 22 France 2 Germany 6 The United Kingdom 3 Spain 2 Rest of Europe 9 Asia-Pacific (Excluding Japan) 10 Middle East 1
Click here to request a full table of contents and more details on this project.